Drug Trial Radar · NCT05376150
A Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 in Major Depressive Disorder
Last checked: Nov 20, 2026Latest source record: Sep 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
168
Actual
Start
May 19, 2022
Primary completion
Sep 18, 2023
Study completion Oct 16, 2023
Sponsor
- Lead sponsor
- Xenon Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- May 17, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, Phase 2, double-blind, randomized, parallel-arm, placebo-controlled clinical trial to evaluate the efficacy, safety, and tolerability of XEN1101 in subjects with Major Depressive Disorder.
Conditions
- Major Depressive Disorder
Interventions
XEN1101 10 mgDrug
XEN1101 oral capsule
XEN1101 20 mgDrug
XEN1101 oral capsule
PlaceboDrug
Placebo capsule
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Montgomery-Åsberg Depression Rating Scale (MADRS) Score.Time frame: From baseline to end of treatment (Week 6).
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Advanced Research Center
Anaheim, California
Sunwise Clinical Research, LLC
Lafayette, California
California Neuropsychopharmacology Clinical Research Institute
Pico Rivera, California
Artemis Institute for Clinical Research
Riverside, California
Artemis Institute for Clinical Research
San Diego, California
Meridian International Research
Miami, Florida
Global Medical Institutes (GMI)
Miami, Florida
CCM Clinical Reseach Group, LLC
Miami, Florida
i-Research, Atlanta
Decatur, Georgia
Psych Atlanta, PC
Marietta, Georgia
iResearch
Savannah, Georgia
Revive Research Institute, Inc.
Elgin, Illinois
Altea Research
Las Vegas, Nevada
Hassman Research Institute
Marlton, New Jersey
Bio Behavioral Health
Toms River, New Jersey
Neurobehavioral Research, Inc. (NBR)
Cedarhurst, New York
Manhattan Behavioral Medicine, PLLC
New York, New York
Richard M Weisler and Association
Raleigh, North Carolina
FutureSearch Trials of Dallas, LP
Dallas, Texas
AIM Trials
Plano, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.